Becton Dickinson up on beating Q4 earnings estimates
** Becton Dickinson and Co's shares BDX.N up 2% at $222.60
before the bell
** Medical device maker posts Q4 revenue of $4.76 billion,
beating analysts' average estimates of $4.72 bln, according to
Refinitiv IBES data
** Co's Q4 adjusted profit of $2.75 per share, came above
analysts' estimate of $2.74 per share - Refinitiv IBES data
** Including session gains, stock lost ~9% YTD compared with
a ~7% decline in the S&P 500 healthcare index .SPXHC
(Reporting by Khushi Mandowara)
((Khushi.Mandowara@thomsonreuters.com;))
Recent news on Becton Dickinson and Co
See all newsCorrected: BDx secures data center power contract from Indonesia's PLN
China's commerce ministry holds meeting with foreign pharmaceutical firms
Brief: Becton Dickinson Euro Finance S.À R.L Files For Euro-Denominated 600 Million 3.855% Notes Offering Due 2033 - SEC Filing
U.S. STOCKS ON THE MOVE-Krispy Kreme, Tesla, Axon Enterprise
Becton Dickinson raises 2026 profit forecast on drug delivery devices demand (updated)